Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia
Björn C. Knollmann, … , Clara Franzini-Armstrong, Karl Pfeifer
Björn C. Knollmann, … , Clara Franzini-Armstrong, Karl Pfeifer
Published September 1, 2006
Citation Information: J Clin Invest. 2006;116(9):2510-2520. https://doi.org/10.1172/JCI29128.
View: Text | PDF
Research Article Cardiology

Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia

  • Text
  • PDF
Abstract

Cardiac calsequestrin (Casq2) is thought to be the key sarcoplasmic reticulum (SR) Ca2+ storage protein essential for SR Ca2+ release in mammalian heart. Human CASQ2 mutations are associated with catecholaminergic ventricular tachycardia. However, homozygous mutation carriers presumably lacking functional Casq2 display surprisingly normal cardiac contractility. Here we show that Casq2-null mice are viable and display normal SR Ca2+ release and contractile function under basal conditions. The mice exhibited striking increases in SR volume and near absence of the Casq2-binding proteins triadin-1 and junctin; upregulation of other Ca2+-binding proteins was not apparent. Exposure to catecholamines in Casq2-null myocytes caused increased diastolic SR Ca2+ leak, resulting in premature spontaneous SR Ca2+ releases and triggered beats. In vivo, Casq2-null mice phenocopied the human arrhythmias. Thus, while the unique molecular and anatomic adaptive response to Casq2 deletion maintains functional SR Ca2+ storage, lack of Casq2 also causes increased diastolic SR Ca2+ leak, rendering Casq2-null mice susceptible to catecholaminergic ventricular arrhythmias.

Authors

Björn C. Knollmann, Nagesh Chopra, Thinn Hlaing, Brandy Akin, Tao Yang, Kristen Ettensohn, Barbara E.C. Knollmann, Kenneth D. Horton, Neil J. Weissman, Izabela Holinstat, Wei Zhang, Dan M. Roden, Larry R. Jones, Clara Franzini-Armstrong, Karl Pfeifer

×

Figure 4

Casq2–/– myocytes display spontaneous Ca2+ releases and triggered beats but largely maintain normal contractility, SR Ca2+ release amplitudes, and SR Ca2+ content.

Options: View larger image (or click on image) Download as PowerPoint

Casq2–/–
                  myocytes display spontaneous Ca2+
          ...
(A) Examples of [Ca2+]i transients (top traces) and cell shortening (bottom traces) recorded from fura-2/AM–loaded, field-stimulated myocytes (1 Hz). Application of 1 μmol/l isoproterenol (ISO) significantly increased Ca2+ transients and cell shortening in both myocytes. Note that shortly after ISO application was started, only the Casq2–/–myocyte displayed spontaneous Ca2+ releases and aftercontractions of increasing amplitude following each paced twitch (vertical lines). (B and C) Comparison of the incidence of spontaneous (Spont.) Ca2+ release events (B) and Ca2+ oscillations (C) at baseline and in the presence of ISO. Data represent the fraction (%) of myocytes that displayed at least 1 event during a 20-second recording period. Insets show representative examples of spontaneous Ca2+ after-releases (arrows in B, inset) and Ca2+ oscillations (C, inset) induced by spontaneous Ca2+ releases and triggered beats (# in C, inset). *P < 0.05, **P < 0.01, †P < 0.001, Casq2–/– versus Casq2+/+ myocytes by Fisher’s exact test. Casq2+/+ myocytes: n = 45 (baseline) and 27 (ISO); Casq2–/–myocytes: n = 71 (baseline) and 43 (ISO).

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts